Unknown

Dataset Information

0

Improving clinical benefit for prostate cancer patients through the combination of androgen deprivation and immunotherapy.


ABSTRACT: Androgen-deprivation therapy (ADT) induces prostate cancer immunogenic modulation (IM) by reducing human tumor cell expression of anti-apoptotic genes thus facilitating increased sensitivity to immune-mediated lysis. Through its stimulation of IM, ADT has been shown to synergize with active immunotherapy thereby significantly improving overall survival in a mouse model of prostate cancer.

SUBMITTER: Kwilas AR 

PROVIDER: S-EPMC4485836 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Improving clinical benefit for prostate cancer patients through the combination of androgen deprivation and immunotherapy.

Kwilas Anna R AR   Gameiro Sofia R SR   Kim Peter S PS   Malamas Anthony S AS   Hodge James W JW  

Oncoimmunology 20150302 6


Androgen-deprivation therapy (ADT) induces prostate cancer immunogenic modulation (IM) by reducing human tumor cell expression of anti-apoptotic genes thus facilitating increased sensitivity to immune-mediated lysis. Through its stimulation of IM, ADT has been shown to synergize with active immunotherapy thereby significantly improving overall survival in a mouse model of prostate cancer. ...[more]

Similar Datasets

| S-EPMC7187215 | biostudies-literature
| S-EPMC5669826 | biostudies-literature
| S-EPMC5332936 | biostudies-literature
| S-EPMC5873299 | biostudies-literature
| S-EPMC3349783 | biostudies-literature
| S-EPMC9234014 | biostudies-literature
| S-EPMC9738737 | biostudies-literature
| S-EPMC7886363 | biostudies-literature
| S-EPMC5291449 | biostudies-literature
| S-EPMC8126326 | biostudies-literature